Please check your internet connection and try again.
## Overview
Ecospirin is an enteric-coated aspirin product. Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that acts as an antiplatelet agent, analgesic, antipyretic, and anti-inflammatory. The enteric coating is designed to delay absorption and reduce gastrointestinal irritation.
## Primary Indications
* **Cardiovascular protection:** Primary and secondary prevention of myocardial infarction and stroke.
* **Analgesia and antipyresis:** Mild to moderate pain and fever.
* **Anti-inflammatory:** Inflammatory conditions (though higher doses are typically required than for antiplatelet therapy).
## Adult Dosing
* **Cardiovascular protection:** Typically 75-100 mg once daily. Higher doses (e.g., 325 mg) may be used initially in certain acute situations or as directed by protocol.
* **Analgesia/Antipyresis:** 325-650 mg every 4-6 hours as needed, not to exceed 4000 mg/day.
* **Anti-inflammatory:** 2400-3600 mg/day in divided doses every 6-8 hours.
## Pediatric Dosing
Aspirin is generally **not recommended** for children or teenagers due to the risk of Reye's syndrome, particularly during viral illnesses. Specific indications and dosing in pediatrics, if any, must be guided by expert consensus and may vary significantly.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised, especially in severe disease, due to potential for accumulation and increased adverse effects.
## Contraindications
* Hypersensitivity to aspirin, salicylates, or NSAIDs.
* History of aspirin-induced asthma, urticaria, or other allergic-type reactions.
* Active peptic ulceration or recent gastrointestinal bleeding.
* Bleeding disorders (e.g., hemophilia).
* Severe hepatic or renal impairment.
* Children and teenagers with viral infections (risk of Reye's syndrome).
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, occult bleeding, ulceration, perforation.
* **Hematologic:** Increased bleeding time, bruising, epistaxis, petechiae, prolonged hemorrhage.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus, dizziness, headache, confusion.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Alcohol:** Increased risk of GI irritation and bleeding.
* **Methotrexate:** Aspirin may increase methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Aspirin can decrease the efficacy of uricosuric agents.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** Aspirin may reduce their antihypertensive effect.
## Monitoring
* **Bleeding:** Monitor for signs and symptoms of bleeding (e.g., hematemesis, melena, bruising, epistaxis).
* **GI symptoms:** Assess for dyspepsia, abdominal pain, or other GI distress.
* **Renal function:** Consider monitoring in patients with pre-existing renal disease or those at risk.
* **Tinnitus:** May indicate salicylate toxicity.
## Clinical Pearls
* The enteric coating of Ecospirin is intended to be swallowed whole and should not be crushed, chewed, or broken to maintain its protective properties.
* For acute cardiovascular events (e.g., suspected MI), non-enteric coated aspirin is often preferred for faster absorption.
* Patients with a history of peptic ulcer disease or GI bleeding should use aspirin with extreme caution, and often alternative agents are preferred.
* Regular use of aspirin for pain relief requires monitoring for cumulative toxicity and GI side effects.
***
*Please verify the current prescribing information and local protocols before initiating or modifying drug therapy.*
